Hybrid endoscopy system could detect early ovarian cancer
The combining of three imaging tools into one device may provide a new, minimally invasive approach to diagnosing early-stage ovarian cancer in high-risk women.
Cancer Symptoms
CIPN: Treatment preservation and prevention are the goals
CIPN is a debilitating adverse effect that can lead to reduced doses that hinder treatment effectiveness or early discontinuation of therapy.
Pneumothorax, hemorrhage risks may outweigh benefits of pulmonary biopsy
Transthoracic needle biopsy of a pulmonary nodule often results in pneumothorax that requires chest-tube placement, a team of investigators has found.
ACOG now calls for annual mammograms starting at 40 years
The American College of Obstetricians and Gynecologists has revised its mammography screening recommendation, now suggesting that women have the test once a year starting at age 40 years.
New screening protocol for pancreatic cancer is better than standard means
Using the CA 19-9 tumor marker followed by an endoscopic ultrasound is more likely to detect stage 1 pancreatic cancer in persons at high risk for the disease than is using CA 19-9 alone.
Dignity therapy improves end-of-life experience
A form of psychotherapy that is intended to relieve distress for dying patients and their families showed great effectiveness in a recent study.
New drug helps control rare sarcoma disease
The experimental agent cediranib shrank tumors in more than half of study subjects afflicted with alveolar soft part sarcoma (ASPS).
Basic steps are best bet for detecting gynecologic cancer recurrence
The best approach for detecting most gynecologic cancer recurrences is to take a thorough history, perform a thorough examination, and educate the patient about concerning symptoms.
Differentiating type is key to non-Hodgkin lymphomas
Management and prognosis for patients with NHL depend on identifying the disease type. This review discusses the diagnoses and optimal treatments.
Abstral approved for breakthrough cancer pain
A tablet delivering transmucosal fentanyl, Abstral is indicated for the management of breakthrough pain in adult cancer patients who are already using opioids around the clock.
- Loading...
Loading...
Loading... 
Loading...